Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study

Sponsor
NYU Langone Health (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03473782
Collaborator
(none)
200
1
81.8
2.4

Study Details

Study Description

Brief Summary

This is a prospective cohort study study with the primary aim of identifying the strongest correlating parameters between voiding diaries and UDS studies most predictive for each type of urologic condition. Investigators will focus on OAB related conditions, as these are symptoms

Condition or Disease Intervention/Treatment Phase
  • Other: Voiding Diary
  • Other: Urodynamics Correlation Study

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study
Actual Study Start Date :
Sep 1, 2016
Anticipated Primary Completion Date :
Jun 27, 2023
Anticipated Study Completion Date :
Jun 27, 2023

Arms and Interventions

Arm Intervention/Treatment
Voiding Diary

Other: Voiding Diary
A log kept by each patient to record frequency and volume of urine output and fluid input.

Other: Urodynamics Correlation Study
Provides patho physiological data by assessing bladder sensation, bladder capacity, the presence of involuntary bladder contractions, bladder compliance and bladder outlet obstruction.

Urodynamics Correlation Study

Other: Voiding Diary
A log kept by each patient to record frequency and volume of urine output and fluid input.

Other: Urodynamics Correlation Study
Provides patho physiological data by assessing bladder sensation, bladder capacity, the presence of involuntary bladder contractions, bladder compliance and bladder outlet obstruction.

Outcome Measures

Primary Outcome Measures

  1. Measure of urgency incontinence using Voiding Diary [60 Months]

    patients will record urgency in diary

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 110 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • completing a bladder diary

  • undergoing VUDS

Exclusion Criteria:
  • have a urinary tract infection

  • neurogenic bladder

  • history of pelvic irradiation

  • prolapse alone without LUTS

  • pregnant

  • incarcerated

  • hospital employee

  • unable to give consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York University School of Medicine New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Benjamin Brucker, NYU Langone Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03473782
Other Study ID Numbers:
  • 15-00827
First Posted:
Mar 22, 2018
Last Update Posted:
Aug 19, 2022
Last Verified:
Aug 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 19, 2022